Analystreport

Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $15.00 price target on the stock.

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com